A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 3, Issue 12, Pages e335-e335
Publisher
Springer Nature
Online
2013-12-17
DOI
10.1038/tp.2013.110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia
- (2013) Alejandro Ballesteros et al. SCHIZOPHRENIA RESEARCH
- Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials
- (2012) Stephen P Juraschek et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Molecular Mechanisms of Hypertension—Reactive Oxygen Species and Antioxidants: A Basic Science Update for the Clinician
- (2012) Augusto C. Montezano et al. CANADIAN JOURNAL OF CARDIOLOGY
- Eicosapentaenoic Acid Interventions in Schizophrenia
- (2012) Paolo Fusar-Poli et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis
- (2012) J G Martins et al. MOLECULAR PSYCHIATRY
- Genome-wide profiling of multiple histone methylations in olfactory cells: further implications for cellular susceptibility to oxidative stress in schizophrenia
- (2012) S Kano et al. MOLECULAR PSYCHIATRY
- Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells
- (2012) H. Bentsen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder
- (2011) Håvard Bentsen et al. BIOLOGICAL PSYCHIATRY
- N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development
- (2011) Joao Miguel das Neves Duarte et al. BIOLOGICAL PSYCHIATRY
- Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients
- (2011) Monia Raffa et al. BMC Psychiatry
- Emerging drugs for schizophrenia
- (2011) Falko Biedermann et al. EXPERT OPINION ON EMERGING DRUGS
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Oxidative Stress and Central Cardiovascular Regulation
- (2010) Yoshitaka Hirooka et al. CIRCULATION JOURNAL
- The omega-3 fatty acids EPA and DHA decrease plasma F2-isoprostanes: Results from two placebo-controlled interventions
- (2010) Emilie Mas et al. FREE RADICAL RESEARCH
- Antioxidant Vitamins and Their Use in Preventing Cardiovascular Disease
- (2010) Dan Farbstein et al. MOLECULES
- Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia
- (2010) M.M. Sethom et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future
- (2010) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Redox dysregulation, neurodevelopment, and schizophrenia
- (2009) Kim Q Do et al. CURRENT OPINION IN NEUROBIOLOGY
- Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
- (2009) Vidhi Singh et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- MMRM vs. LOCF: A Comprehensive Comparison Based on Simulation Study and 25 NDA Datasets
- (2009) Ohidul Siddiqui et al. Journal of Biopharmaceutical Statistics
- Vitamin E Supplementation and Hepatic Drug Metabolism in Humans
- (2009) Michael W Clarke et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia
- (2009) Susan J. van Rensburg et al. METABOLIC BRAIN DISEASE
- From Real-World Events to Psychosis: The Emerging Neuropharmacology of Delusions
- (2009) P. D. Morrison et al. SCHIZOPHRENIA BULLETIN
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Skin fibroblast model to study an impaired glutathione synthesis: Consequences of a genetic polymorphism on the proteome
- (2008) René Gysin et al. BRAIN RESEARCH BULLETIN
- Vitamin E: The shrew waiting to be tamed
- (2008) Regina Brigelius-Flohé FREE RADICAL BIOLOGY AND MEDICINE
- Very-high-dose α-tocopherol supplementation increases blood pressure and causes possible adverse central nervous system effects in stroke-prone spontaneously hypertensive rats
- (2008) Kaori Miyamoto et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Δ-9-tetrahydrocannabinol in humans
- (2008) Deepak Cyril D’Souza et al. PSYCHOPHARMACOLOGY
- Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome
- (2007) Sridevi Devaraj et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started